MeSH term
Frequency | Condition_Probility | Animals | 28 | 0.0 |
Cattle | 11 | 0.0 |
Cells, Cultured | 6 | 0.0 |
Humans | 56 | 0.0 |
Immunoblotting | 2 | 0.0 |
Plasmids/metabolism | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 38 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 23 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 4 | 0.0 |
Time Factors | 3 | 0.0 |
Transfection | 4 | 0.0 |
*Extracellular Matrix Proteins | 39 | 28.0 |
Male | 15 | 0.0 |
Rats | 11 | 0.0 |
Rats, Sprague-Dawley | 2 | 0.0 |
Adult | 7 | 0.0 |
Aged | 9 | 0.0 |
Aged, 80 and over | 4 | 0.0 |
Arteriosclerosis/*metabolism | 3 | 4.0 |
Female | 14 | 0.0 |
Immunohistochemistry/methods | 2 | 0.0 |
Middle Aged | 7 | 0.0 |
Cell Line | 9 | 0.0 |
Immunohistochemistry | 7 | 0.0 |
Mice | 9 | 0.0 |
Phosphorylation | 3 | 0.0 |
Protein Binding | 3 | 0.0 |
*Transforming Growth Factor beta | 6 | 4.0 |
Blotting, Western | 2 | 0.0 |
Bone and Bones/*metabolism | 2 | 2.0 |
Calcium/*metabolism | 3 | 0.0 |
Vitamin K/metabolism | 2 | 11.0 |
Comparative Study | 7 | 0.0 |
RNA, Messenger/analysis | 3 | 0.0 |
Cloning, Molecular | 3 | 0.0 |
DNA, Complementary | 2 | 0.0 |
Gene Expression | 4 | 0.0 |
Molecular Sequence Data | 12 | 0.0 |
Sequence Homology, Amino Acid | 3 | 0.0 |
Arteriosclerosis/*pathology | 2 | 7.0 |
Calcinosis/*pathology | 3 | 30.0 |
Vitamin K/*physiology | 3 | 42.0 |
Calcinosis/*genetics | 2 | 50.0 |
Calcium-Binding Proteins/*genetics | 9 | 10.0 |
Gene Expression Regulation/drug effects | 3 | 0.0 |
Transforming Growth Factor beta/pharmacology | 2 | 0.0 |
Cell Differentiation | 4 | 0.0 |
Calcium-Binding Proteins/*biosynthesis/genetics | 2 | 25.0 |
Down-Regulation | 2 | 0.0 |
Gene Library | 3 | 0.0 |
In Situ Hybridization | 5 | 0.0 |
RNA, Messenger/biosynthesis | 2 | 0.0 |
Conserved Sequence | 2 | 0.0 |
Adolescent | 2 | 0.0 |
Alleles | 5 | 0.0 |
Gene Frequency | 2 | 0.0 |
Genotype | 3 | 0.0 |
Risk Factors | 2 | 0.0 |
Calcium-Binding Proteins/physiology | 2 | 18.0 |
Muscle, Smooth, Vascular/*pathology | 2 | 18.0 |
Species Specificity | 2 | 0.0 |
Tunica Media/pathology | 2 | 16.0 |
Calcium-Binding Proteins/genetics | 3 | 7.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 2 | 0.0 |
Transcription Factors/genetics | 2 | 0.0 |
Calcium-Binding Proteins/*genetics/metabolism | 2 | 13.0 |
Osteoblasts/*metabolism | 2 | 3.0 |
RNA, Messenger/genetics | 2 | 0.0 |
Calcification, Physiologic | 2 | 13.0 |
*Chromosomes, Human, Pair 12 | 2 | 0.0 |
Chromatography, Gel | 2 | 0.0 |
Binding Sites | 2 | 0.0 |
Cell Division | 2 | 0.0 |
*Promoter Regions (Genetics) | 3 | 0.0 |
Base Sequence | 7 | 0.0 |
Chromosome Mapping | 2 | 0.0 |
Polymerase Chain Reaction | 2 | 0.0 |
Polymorphism, Genetic | 2 | 0.0 |
Tretinoin/*pharmacology | 2 | 0.0 |
Antibodies, Monoclonal | 2 | 0.0 |
Blotting, Northern | 4 | 0.0 |
Calcinosis/*metabolism | 3 | 42.0 |
Amino Acid Sequence | 9 | 0.0 |
Restriction Mapping | 2 | 0.0 |
Sialoglycoproteins/*genetics/physiology | 2 | 100.0 |
Molecular Weight | 2 | 0.0 |
Cycloheximide/pharmacology | 2 | 0.0 |
RNA, Messenger/*analysis | 2 | 0.0 |
Microscopy, Electron | 2 | 0.0 |
